ingenious targeting laboratory Secures Extended Contract With Top 10 Pharma for Humanized Mouse Models

    RONKONKOMA, NY, July 25, 2016 /24-7PressRelease/ -- ingenious targeting laboratory (www.genetargeting.com), a leading global provider of genetically modified mouse models, announced today that they have solidified an extended contract with one of its top 10 pharma clients for creating complex and large scale humanized mouse models utilizing their exclusive gene targeting technologies. ingenious is always investing in new technologies and services in anticipation of industry needs. This has garnered considerable interest from companies and institutes regarding ingenious' ability to achieve increasingly challenging designs in a fraction of the time when compared to competitors. ingenious is pleased to be able to provide a solution to this pharma's requests and offer these services to researchers worldwide.

As the spike in translational research continues, there will be an increased need for animal models that better recapitulate human phenotypes. Traditional methods of creating humanized mouse models manipulate only relatively small portions of the genes of interest, and therefore are limited in their true representation of human gene function. For those companies who do offer larger targeting options, the timelines to generate such complex models are long. ingenious' combination of experience and unique technology offer a solution to the challenges presented by standard methods to humanize the mouse, allowing complex and large scale targeting to be achieved within a year time frame.

Mr. Michael Castelli, Sales and Marketing Manager of ingenious, stated, "Our recent success in securing this contract demonstrates the value of our technology, as well as its importance to research and development efforts throughout the pharma and biotech industry."

Paul Sheiffele, President of ingenious, added, "The most compelling reason to use ingenious' services is the constant success in model generation that we provide to each of our clients again and again. With nearly two decades of operations and timelines that are two times faster than competitors, we look forward to continued growth in this market."

For more information about our technology, visit http://www.genetargeting.com

Established in 1998, ingenious targeting laboratory exclusively creates mice whose genetic make-up is tailored to the client's research needs. Clients retain all intellectual property rights to their projects. A full range of project capabilities are available including: conventional and conditional knockouts, knockin models (humanized, inducible, reporter gene/cassette insertion, point mutations), as well as novel approaches for customized mouse models. Projects are initiated immediately upon completion of design parameters and progress to completion on-site in the USA, under the supervision of a dedicated scientific Project Manager. ingenious is located in Ronkonkoma, New York.

# # #